These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Pediatric craniopharyngioma: long-term results in 61 cases]. Pancucci G; Massimi L; Caldarelli M; D'Angelo L; Sturiale C; Tamburrini G; Tufo T; Di Rocco C Minerva Pediatr; 2007 Jun; 59(3):219-31. PubMed ID: 17519867 [TBL] [Abstract][Full Text] [Related]
5. Craniopharyngiomas: intratumoral chemotherapy with interferon-alpha: a multicenter preliminary study with 60 cases. Cavalheiro S; Di Rocco C; Valenzuela S; Dastoli PA; Tamburrini G; Massimi L; Nicacio JM; Faquini IV; Ierardi DF; Silva NS; Pettorini BL; Toledo SR Neurosurg Focus; 2010 Apr; 28(4):E12. PubMed ID: 20367356 [TBL] [Abstract][Full Text] [Related]
6. Intracystic interferon-α treatment leads to neurotoxicity in craniopharyngioma: case report. Sharma J; Bonfield CM; Singhal A; Hukin J; Steinbok P J Neurosurg Pediatr; 2015 Sep; 16(3):301-4. PubMed ID: 26023721 [TBL] [Abstract][Full Text] [Related]
7. Endoscopic transventricular positioning of intracystic catheter for treatment of craniopharyngioma. Technical note. Pettorini BL; Tamburrini G; Massimi L; Caldarelli M; Di Rocco C J Neurosurg Pediatr; 2009 Sep; 4(3):245-8. PubMed ID: 19772408 [TBL] [Abstract][Full Text] [Related]
8. The role of inflammation in the genesis of the cystic component of craniopharyngiomas. Pettorini BL; Inzitari R; Massimi L; Tamburrini G; Caldarelli M; Fanali C; Cabras T; Messana I; Castagnola M; Di Rocco C Childs Nerv Syst; 2010 Dec; 26(12):1779-84. PubMed ID: 20668862 [TBL] [Abstract][Full Text] [Related]
9. Phase II evaluation of interferon-alpha-2a for progressive or recurrent craniopharyngiomas. Jakacki RI; Cohen BH; Jamison C; Mathews VP; Arenson E; Longee DC; Hilden J; Cornelius A; Needle M; Heilman D; Boaz JC; Luerssen TG J Neurosurg; 2000 Feb; 92(2):255-60. PubMed ID: 10659012 [TBL] [Abstract][Full Text] [Related]
10. Intracystic interferon-alpha in pediatric craniopharyngioma patients: an international multicenter assessment on behalf of SIOPE and ISPN. Kilday JP; Caldarelli M; Massimi L; Chen RH; Lee YY; Liang ML; Parkes J; Naiker T; van Veelen ML; Michiels E; Mallucci C; Pettorini B; Meijer L; Dorfer C; Czech T; Diezi M; Schouten-van Meeteren AYN; Holm S; Gustavsson B; Benesch M; Müller HL; Hoffmann A; Rutkowski S; Flitsch J; Escherich G; Grotzer M; Spoudeas HA; Azquikina K; Capra M; Jiménez-Guerra R; MacDonald P; Johnston DL; Dvir R; Constantini S; Kuo MF; Yang SH; Bartels U Neuro Oncol; 2017 Oct; 19(10):1398-1407. PubMed ID: 28499018 [TBL] [Abstract][Full Text] [Related]
11. Pegylated interferon-α-2b for children with recurrent craniopharyngioma. Yeung JT; Pollack IF; Panigrahy A; Jakacki RI J Neurosurg Pediatr; 2012 Dec; 10(6):498-503. PubMed ID: 23061825 [TBL] [Abstract][Full Text] [Related]
12. Craniopharyngioma in children: Marseille experience. Lena G; Paz Paredes A; Scavarda D; Giusiano B Childs Nerv Syst; 2005 Aug; 21(8-9):778-84. PubMed ID: 16133277 [TBL] [Abstract][Full Text] [Related]
13. Craniopharyngioma: treatment in the CT and MR imaging era. Mark RJ; Lutge WR; Shimizu KT; Tran LM; Selch MT; Parker RG Radiology; 1995 Oct; 197(1):195-8. PubMed ID: 7568823 [TBL] [Abstract][Full Text] [Related]
14. Long-term outcome and reconsideration of intracystic chemotherapy with bleomycin for craniopharyngioma in children. Takahashi H; Yamaguchi F; Teramoto A Childs Nerv Syst; 2005 Aug; 21(8-9):701-4. PubMed ID: 15928963 [TBL] [Abstract][Full Text] [Related]
15. Influence of interferon alpha on expression of Fas and Fas ligand in dendritic cells from patients with chronic myeloid leukemia. Zhao WL; Chai YH; He HL; Wei XC; Wang T; Xing PN; Li MS Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Jun; 16(3):501-5. PubMed ID: 18549617 [TBL] [Abstract][Full Text] [Related]
16. Craniopharyngiomas in children: surgical experience at Children's Memorial Hospital. Tomita T; Bowman RM Childs Nerv Syst; 2005 Aug; 21(8-9):729-46. PubMed ID: 16044343 [TBL] [Abstract][Full Text] [Related]
17. Craniopharyngiomas: A systematic review and evaluation of the current intratumoral treatment landscape. Mrowczynski OD; Langan ST; Rizk EB Clin Neurol Neurosurg; 2018 Mar; 166():124-130. PubMed ID: 29408768 [TBL] [Abstract][Full Text] [Related]
18. Intracystic gadolinium-enhanced MRI in the evaluation of residual giant-cystic craniopharyngiomas in children: report of four cases. Muñoz A; Martínez-León M; Vázquez É; Pérez da Rosa S; Crespo J J Neuroimaging; 2014; 24(4):393-8. PubMed ID: 23157657 [TBL] [Abstract][Full Text] [Related]
19. Vascular complications in pediatric craniopharyngioma patients: a case-based update. Sandvik U; Ohlsson M; Edström E Childs Nerv Syst; 2019 Dec; 35(12):2273-2278. PubMed ID: 31667536 [TBL] [Abstract][Full Text] [Related]
20. Intratumoral therapy with bleomycin for cystic craniopharyngiomas in children. Hader WJ; Steinbok P; Hukin J; Fryer C Pediatr Neurosurg; 2000 Oct; 33(4):211-8. PubMed ID: 11124639 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]